Search
for
Sort by
Research 481–510 of 1000+
- Two cases of low-prostate-specific antigen localized prostate cancer incidentally detected by computed tomography
- EFFECT OF A COMBINATION OF DUTASTERIDE AND PARENTERAL TESTOSTERONE UNDECANOATE ON TESTOSTERONE DEFICIENCY SYMPTOMS AND PROSTATE IN PATIENTS WITH TESTOSTERONE DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA
- Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele
- DEVELOPMENT OF CHEMICAL FINGERPRINTS TO DIFFERENTIATE THE CONTROVERSIAL INDIAN HERBAL DRUGS ECLIPTA PROSTRATA AND WEDELIA CALENDULACEA (BHRINGRAJA)
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Propecia: The Goose That Lays the Golden Eggs
- 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- A Review on the Clinical Utility of PSA in Cancer Prostate
- Prostate Cancer Early Detection, Version 2.2015
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
- Is dehydroepiandrosterone a hormone?
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Cardiovascular effects of hormone therapy for prostate cancer
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism